Boston Scientific Corporation: Atrial Fibrillation trials

The registry lists 70 Atrial Fibrillation studies with Boston Scientific Corporation as lead sponsor. 7 are open to participants now and 32 have results posted.

Phase 2 2Phase 3 5Phase 4 2No phase 63(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial FibrillationNot yet recruitingNCT07820930Not applicable
• Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial FibrillationRecruitingNCT07575269Not applicable
• Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA SystemRecruitingNCT07444320Not applicable
• OPTION-EMEA Clinical TrialRecruitingNCT07349121Not applicable
• Elite AF IDE Trial (Elite AF)RecruitingNCT07287436Not applicable
• PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)RecruitingNCT07106970Not applicable
• Feasibility Study of the FARAFLEX Mapping and PFA SystemRecruitingNCT06510556Not applicable
• HEAL-LAA Clinical TrialCompletedNCT05809596Not applicableResults posted
• A RWS of the FARAPULSE in A Chinese Population With PAFCompletedNCT05493852Results posted
• A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial FibrillationCompletedNCT05443594Not applicableResults posted
• POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART)CompletedNCT05282823Results posted
• The FARAPULSE PersAFOne III Trial for the Treatment of Persistent Atrial FibrillationCompletedNCT05272852Not applicableResults posted
• Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)CompletedNCT05152966Not applicableResults posted
• The FARAPULSE FARA-Freedom TrialCompletedNCT05072964Not applicableResults posted
• LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance StudyCompletedNCT04732728Results posted
• The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial FibrillationCompletedNCT04612244Not applicableResults posted
• Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial FibrillationCompletedNCT04580914Not applicableResults posted
• A Single Arm Pilot Study of Pulsed Field Ablation in the Treatment of Paroxysmal Atrial FibrillationCompletedNCT04474054Not applicableResults posted
• POLARx Cardiac Cryoablation System StudyCompletedNCT04250714Results posted
• Feasibility Study of the FARAPULSE Endocardial Multi Ablation System in the Treatment of Persistent Atrial FibrillationCompletedNCT04170621Not applicableResults posted
• PEFCATII Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial FibrillationCompletedNCT04170608Not applicableResults posted
• Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial FibrillationCompletedNCT04133168Not applicableResults posted
• Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong KongCompletedNCT04096963Results posted
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF AblationCompletedNCT03795298Not applicableResults posted
• Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial FibrillationCompletedNCT03729830Results posted
• Cryoablation System FIM/CE Mark StudyCompletedNCT03723070Not applicableResults posted
• A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial FibrillationCompletedNCT03714178Not applicableResults posted
• IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial FibrillationCompletedNCT03700385Not applicableResults posted
• IMPACT: A Safety and Feasibility Study of the IOWA Approach Cardiac Ablation SystemCompletedNCT03700372Results posted
• Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial FibrillationCompletedNCT03232645Not applicableResults posted
• A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003WCompletedNCT03033134Not applicableResults posted
• Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure TechnologyCompletedNCT02702271Not applicableResults posted
• Registry on WATCHMAN Outcomes in Real-Life UtilizationCompletedNCT01972282Results posted
• Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure TechnologyCompletedNCT01760291Not applicableResults posted
• Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial FibrillationCompletedNCT01687166Not applicableResults posted
• Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin TherapyCompletedNCT01182441Phase 3Results posted
• TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure PatientsCompletedNCT00345592Phase 4Results posted
• MODULA Modul 7 VRRTerminatedNCT00180414Not applicableResults posted
• WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial FibrillationCompletedNCT00129545Phase 2/3Results posted
• A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial FibrillationActive, not recruitingNCT07187115Not applicable
• A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial FibrillationActive, not recruitingNCT06808217
• FARAPULSE™ Pulsed Field Ablation SystemActive, not recruitingNCT06762717
• Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation SystemActive, not recruitingNCT06735534Not applicable
• cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-AsiaActive, not recruitingNCT06686485
• FARAPULSE Workflow Assessment RegistryActive, not recruitingNCT06656884
• ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression StudyCompletedNCT06526546
• SIMPLAAFY Clinical TrialActive, not recruitingNCT06521463Not applicable
• ADVENT Post Approval StudyActive, not recruitingNCT06431815
• Feasibility Study on the FARAVIEW TechnologyCompletedNCT06175234Not applicable
• POLARx Post Approval Study (POLARx PAS)CompletedNCT06170606Not applicable
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationActive, not recruitingNCT06096337Not applicable
• Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation SystemActive, not recruitingNCT05501873
• Electrical Coupling Information From The RHYTHMIA HDx Mapping System and DIRECTSENSE Technology In The Treatment of Paroxysmal Atrial Fibrillation (LOCALIZE CF)CompletedNCT04740801Not applicable
• CHAMPION-AF Clinical TrialActive, not recruitingNCT04394546Not applicable
• Boston Scientific's Single Shot LUMINIZE RF Balloon Catheter in the Treatment of Symptomatic, Drug Refractory Paroxysmal Atrial FibrillationWithdrawnNCT03852420Not applicable
• WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation RhythmWithdrawnNCT03835338Not applicable
• Data Collection Atrial Fibrillation Exploratory StudyTerminatedNCT03647085
• Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)WithdrawnNCT03613831
• Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)CompletedNCT02654470
• Registry on WATCHMAN Outcomes in Real-Life Utilization WASP RegistryCompletedNCT01972295
• Signal Transfer of Atrial Fibrillation Data to Guide Human TreatmentCompletedNCT01765075
• Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)CompletedNCT01196897Not applicable
• First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator DataCompletedNCT01161589
• ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure TechnologyCompletedNCT00851578Not applicable
• Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study -CompletedNCT00848445Phase 4
• Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA ClassCompletedNCT00292539
• Safety and Efficacy of CryoCor™ Cryoablation for PAFCompletedNCT00231296Not applicable
• Safety and Efficacy Study of RENEWAL 4 AVTCompletedNCT00180336Phase 2/3
• CONTAK RENEWAL 3 AVTCompletedNCT00158977Phase 3
• Guidant Microwave Ablation System for the Treatment of Atrial FibrillationTerminatedNCT00111488Phase 3